In brief
TARGETING HIF-1α DYSFUNCTION TO TREAT PRESSURE ULCERS IN THE AGED is a nursing research record that should be interpreted using the available source metadata.
What this article is about
Quick Answer
TARGETING HIF-1α DYSFUNCTION TO TREAT PRESSURE ULCERS IN THE AGED is a nursing research record that should be interpreted using the available source metadata.
Student takeaways
Key Takeaways
- The database record does not provide key finding 1.
- The database record does not provide key finding 2.
- The database record does not provide key finding 3.
- The database record does not provide key finding 4.
- The database record does not provide key finding 5.
Student summary
Why This Research Matters
This article, a research project summary funded by the National Institute on Aging (NIA), focuses on developing new therapies to treat pressure ulcers in older adults. Pressure ulcers are painful skin injuries that can occur when someone is bedridden or confined to a wheelchair for long periods; they affect millions of people and cost billions annually. The study aims to address this significant healthcare challenge, particularly as the population over 65 years old grows rapidly.
The research builds on previous findings from the same team, which showed that aging leads to changes in molecular pathways important for wound healing, specifically involving a protein called Hypoxia-Inducible Factor 1-alpha (HIF-1α). The authors propose that these changes can be reversed using an FDA-approved drug named Deferoxamine (DFO).
The project is structured into three main aims: 1. **Specific Aim 1:** Define the differences in HIF-1α function and signaling pathways between healthy, unwounded skin from young individuals and older adults. 2. **Specific Aim 2:** Confirm that these identified changes in HIF-1α signaling are also present in pressure ulcers taken as biopsies from both younger and older patients who have developed such wounds. 3. **Specific Aim 3:** Determine the best way to deliver DFO through intact skin, which is necessary for treating pressure ulcers on living people. This will be tested using a porcine (pig) model because pig skin closely resembles human skin in many ways. The study aims to validate an effective drug delivery system that could also potentially be used for other similar drugs.
For nursing students, this research highlights several important aspects: * **Nursing Problem:** Pressure ulcers are a common and serious issue in geriatric care, requiring significant time, resources, and specialized wound management skills. This study addresses the need for more effective treatments beyond current standard care. * **Appraisal of Evidence:** While this is a research project summary (not yet published results), students should understand that it outlines a rigorous scientific approach to finding solutions. The use of specific aims, pre-clinical models (like pigs), and established drugs like DFO are key elements of sound research design. * **Source/Right Cautions:** This information comes from NIH RePORTER, which provides public project metadata for funded research grants. It is not a peer-reviewed journal article yet; it's an outline of the planned work. The record indicates that this summary is based on preliminary data and aims to lay groundwork for future human trials.
Source abstract
Study Overview
Project Summary Pressure ulcers affect 2.5 million people in the United States and cost the healthcare system an estimated 11.6 billion dollars annually. A major percentage of affected individuals are over sixty-five years of age and this number is growing rapidly in the United States. A greater incidence of immobility, vascular disease and diabetes is commonly seen in aged populations and places them at an increased risk for developing pressure ulcers. Thus, there is a pressing need to develop new therapies that will effectively treat pressure ulcers in the aged. With prior NIA support, we have found that aging is characterized by the progressive loss of critical molecular and cellular pathways responsible for normal wound healing, specifically hypoxia-inducible factor 1-alpha (HIF- 1α). We have also identified that these changes can be reversed using an FDA-approved small molecule drug, deferoxamine (DFO). Building on our preliminary data, we will first define the aberrations of HIF-1α in healthy, unwounded skin from young and aged patients (Specific Aim 1). We will then confirm the HIF-1α signaling dysfunction in pressure ulcers using biopsy specimens from both young and aged patients. (Specific Aim 2). To define the alterations in hypoxia signaling within the skin cells of young versus aged patients, we will subject the collected tissue for protein analysis and single cell sequencing. We will then determine the optimal delivery system for DFO through both intact stratum corneum as required for treating pressure ulcers in a porcine model (Specific Aim 3). This large animal model is selected since porcine skin has significant similarities to the human skin. Our results will validate the effectiveness of our drug delivery system and provide a novel strategy to deliver other hydrophilic small molecule drugs across intact human skin. Taken together, this pre-clinical study will lay the groundwork for a pilot human trial targeted at treating pressure ulcers with the transdermal DFO delivery system, which will for the first time provide a pharmacologic therapy to treat pressure ulcers in aged patients.
Evidence appraisal
Main Findings
- The database record does not provide key finding 1.
- The database record does not provide key finding 2.
- The database record does not provide key finding 3.
- The database record does not provide key finding 4.
- The database record does not provide key finding 5.
Practice transfer
Clinical Relevance
- Clinical implication 1 should be interpreted cautiously because the database record is limited.
- Clinical implication 2 should be interpreted cautiously because the database record is limited.
- Clinical implication 3 should be interpreted cautiously because the database record is limited.
- Clinical implication 4 should be interpreted cautiously because the database record is limited.
- Clinical implication 5 should be interpreted cautiously because the database record is limited.
Faculty notes
Educational Relevance
TARGETING HIF-1α DYSFUNCTION TO TREAT PRESSURE ULCERS IN THE AGED can be used for source-grounded discussion. The database record does not provide enough detail for a fuller faculty summary.
Critical appraisal
Limitations
- The database record does not provide limitation 1.
- The database record does not provide limitation 2.
- The database record does not provide limitation 3.
Classroom use
Discussion Questions
- Discussion question 1: What does "TARGETING HIF-1α DYSFUNCTION TO TREAT PRESSURE ULCERS IN THE AGED" help nursing students evaluate?
- Discussion question 2: What does "TARGETING HIF-1α DYSFUNCTION TO TREAT PRESSURE ULCERS IN THE AGED" help nursing students evaluate?
- Discussion question 3: What does "TARGETING HIF-1α DYSFUNCTION TO TREAT PRESSURE ULCERS IN THE AGED" help nursing students evaluate?
- Discussion question 4: What does "TARGETING HIF-1α DYSFUNCTION TO TREAT PRESSURE ULCERS IN THE AGED" help nursing students evaluate?
- Discussion question 5: What does "TARGETING HIF-1α DYSFUNCTION TO TREAT PRESSURE ULCERS IN THE AGED" help nursing students evaluate?
- Discussion question 6: What does "TARGETING HIF-1α DYSFUNCTION TO TREAT PRESSURE ULCERS IN THE AGED" help nursing students evaluate?
- Discussion question 7: What does "TARGETING HIF-1α DYSFUNCTION TO TREAT PRESSURE ULCERS IN THE AGED" help nursing students evaluate?
- Discussion question 8: What does "TARGETING HIF-1α DYSFUNCTION TO TREAT PRESSURE ULCERS IN THE AGED" help nursing students evaluate?
- Discussion question 9: What does "TARGETING HIF-1α DYSFUNCTION TO TREAT PRESSURE ULCERS IN THE AGED" help nursing students evaluate?
- Discussion question 10: What does "TARGETING HIF-1α DYSFUNCTION TO TREAT PRESSURE ULCERS IN THE AGED" help nursing students evaluate?
Search-ready answers
Frequently asked questions
What is the main focus of this research project?
The project aims to target HIF-1α dysfunction as a novel therapy for treating pressure ulcers in older adults.
Who are the primary beneficiaries or patients targeted by this study's potential outcomes?
The study focuses on individuals over sixty-five years of age, who are at an increased risk for developing pressure ulcers due to factors like immobility and vascular disease.
What specific molecular pathway is being investigated as a key factor in wound healing issues related to aging?
The research investigates hypoxia-inducible factor 1-alpha (HIF-1α), which is progressively lost with age, impairing normal wound healing.
How does the project plan to address HIF-1α dysfunction identified in aged patients?
The study plans to use an FDA-approved small molecule drug, deferoxamine (DFO), and aims to define its optimal delivery system for treating pressure ulcers.
What is a significant challenge addressed by this research regarding DFO treatment?
A major challenge is delivering DFO through intact stratum corneum effectively. The study will determine the best method using a porcine model, which has skin similar to humans.
Why was a porcine (pig) model chosen for testing drug delivery systems?
Porcine skin was selected because it has significant similarities to human skin, making it suitable for pre-clinical studies of transdermal drug delivery.
What is the ultimate goal regarding patient care after this pre-clinical study?
The ultimate goal is to lay the groundwork for a pilot human trial targeted at treating pressure ulcers with the developed transdermal DFO delivery system, providing a pharmacologic therapy for aged patients.
What are two major economic impacts of pressure ulcers in the United States mentioned in the abstract?
Pressure ulcers affect 2.5 million people and cost the healthcare system an estimated 11.6 billion dollars annually.
Which specific aim involves defining HIF-1α aberrations using patient tissue samples?
Specific Aim 2 confirms HIF-1α signaling dysfunction in pressure ulcers by analyzing biopsy specimens from both young and aged patients.
What advanced techniques are mentioned for analyzing skin cells to understand hypoxia signaling differences between young and aged individuals?
The study will use protein analysis and single cell sequencing on collected tissue samples to define alterations in hypoxia signaling within the skin cells of young versus aged patients.